HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fabrizio De Ponti Selected Research

bis(1- hydroxy- 2,2,6,6- tetramethyl- 4- piperidinyl)decandioate

8/2010Non-peptidyl low molecular weight radical scavenger IAC attenuates DSS-induced colitis in rats.
7/2009Effects of the non-peptidyl low molecular weight radical scavenger IAC in DNBS-induced colitis in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Fabrizio De Ponti Research Topics

Disease

13Torsades de Pointes (Torsade de Pointes)
01/2017 - 01/2002
9Drug-Related Side Effects and Adverse Reactions
01/2020 - 01/2002
7Neoplasms (Cancer)
12/2019 - 03/2008
7Irritable Bowel Syndrome (Syndrome, Irritable Bowel)
11/2019 - 01/2003
7Cardiac Arrhythmias (Arrythmia)
01/2017 - 03/2005
7Inflammation (Inflammations)
07/2013 - 05/2003
6Atrial Fibrillation
12/2019 - 10/2010
6Colitis
12/2010 - 05/2003
5Chemical and Drug Induced Liver Injury
05/2022 - 07/2015
5Type 2 Diabetes Mellitus (MODY)
04/2021 - 04/2015
5COVID-19
02/2021 - 10/2020
4Heart Failure
02/2022 - 01/2018
4Cardiac Sudden Death (Sudden Cardiac Arrest)
01/2021 - 10/2010
4Stroke (Strokes)
12/2019 - 04/2011
4Venous Thromboembolism
12/2019 - 12/2016
4Pain (Aches)
11/2019 - 04/2002
4Myocarditis (Carditis)
09/2019 - 01/2018
4Cardiotoxicity
01/2015 - 03/2005
3Infections
06/2021 - 11/2019
3Acute Liver Failure (Fulminant Hepatic Failure)
12/2020 - 07/2015
3Hemorrhage
10/2017 - 08/2016
3Constipation
02/2014 - 04/2002
3Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
08/2010 - 01/2009
3Dyspepsia (Indigestion)
03/2006 - 01/2003
2Breast Neoplasms (Breast Cancer)
03/2022 - 01/2019
2Pancreatitis
06/2021 - 01/2021
2Thrombosis (Thrombus)
01/2021 - 01/2018
2Mental Disorders (Mental Disorder)
01/2021 - 01/2016
2Tachycardia (Tachyarrhythmias)
09/2019 - 06/2013
2Cardiovascular Diseases (Cardiovascular Disease)
06/2019 - 12/2016
2Pericarditis
12/2018 - 01/2018
2Liver Diseases (Liver Disease)
12/2018 - 04/2015
2Liver Cirrhosis (Hepatic Cirrhosis)
12/2018 - 11/2012
2Multiple Sclerosis
09/2018 - 01/2017
2Diarrhea
01/2018 - 05/2003
2Human Influenza (Influenza)
01/2018 - 01/2018
2Demyelinating Diseases (Demyelinating Disease)
01/2018 - 01/2018
2Fibrosis (Cirrhosis)
06/2017 - 11/2012
2Hypertension (High Blood Pressure)
01/2015 - 09/2005
2Heart Arrest (Cardiac Arrest)
01/2015 - 10/2010
2Osteoporosis
07/2014 - 01/2014
2Ventricular Fibrillation
06/2013 - 03/2005
2Body Weight (Weight, Body)
07/2009 - 01/2009
2Long QT Syndrome
03/2005 - 01/2002
1Alopecia (Baldness)
03/2022
1Dermatitis
03/2022
1Erythema Multiforme
03/2022
1Vitiligo
03/2022
1Gambling (Pathological Gambling)
01/2022
1Disruptive, Impulse Control, and Conduct Disorders (Kleptomania)
01/2022

Drug/Important Bio-Agent (IBA)

32Pharmaceutical PreparationsIBA
01/2022 - 01/2002
5Antipsychotic Agents (Antipsychotics)IBA
01/2022 - 03/2005
4Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2022 - 04/2011
42,4-dinitrofluorobenzene sulfonic acidIBA
07/2009 - 05/2003
3Cyclin-Dependent Kinase 4IBA
03/2022 - 01/2019
3Sodium-Glucose Transport ProteinsIBA
02/2022 - 12/2018
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2022 - 01/2009
3Sodium-Glucose Transporter 2 InhibitorsIBA
04/2021 - 01/2019
3FluoroquinolonesIBA
01/2021 - 03/2005
3dimethylethylsilylimidazoleIBA
01/2021 - 12/2020
3Glucose (Dextrose)FDA LinkGeneric
01/2020 - 12/2018
3AnticoagulantsIBA
12/2019 - 06/2017
3Opioid Analgesics (Opioids)IBA
11/2019 - 04/2002
3VaccinesIBA
12/2018 - 01/2018
3Factor Xa InhibitorsIBA
01/2018 - 08/2016
3Ether (Diethyl Ether)IBA
01/2017 - 01/2002
3Histamine Antagonists (Antihistamines)IBA
01/2017 - 03/2005
3Proton Pump InhibitorsIBA
05/2016 - 01/2003
3Anti-Arrhythmia AgentsIBA
02/2011 - 01/2002
3AcidsIBA
01/2004 - 01/2003
2ribociclibIBA
03/2022 - 04/2021
2abemaciclibIBA
03/2022 - 04/2021
2sacubitril and valsartan sodium hydrate drug combinationIBA
02/2022 - 01/2021
2ceftazidime drug combination avibactamIBA
06/2021 - 11/2019
2tazobactam drug combination ceftolozaneIBA
06/2021 - 01/2021
2Anti-Bacterial Agents (Antibiotics)IBA
06/2021 - 11/2019
2Immune Checkpoint InhibitorsIBA
01/2021 - 01/2018
2tocilizumab (atlizumab)FDA Link
01/2021 - 01/2021
2Dipeptidyl-Peptidase IV InhibitorsIBA
01/2020 - 01/2016
2Anticonvulsants (Antiepileptic Drugs)IBA
11/2019 - 01/2018
2Hypoglycemic Agents (Hypoglycemics)IBA
06/2019 - 12/2018
2SodiumIBA
06/2019 - 08/2010
2Immunosuppressive Agents (Immunosuppressants)IBA
01/2019 - 04/2013
2Vitamin KFDA Link
10/2017 - 06/2017
2Phytoestrogens (Phytoestrogen)IBA
07/2014 - 01/2014
2Amiodarone (Amiodarona)FDA LinkGeneric
03/2013 - 10/2010
2Serotonin (5 Hydroxytryptamine)IBA
07/2011 - 01/2003
2Oxygen (Dioxygen)IBA
08/2010 - 07/2009
2bis(1- hydroxy- 2,2,6,6- tetramethyl- 4- piperidinyl)decandioateIBA
08/2010 - 07/2009
2Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
03/2006 - 12/2004
1nintedanibIBA
05/2022
1palbociclibIBA
03/2022
1Cyclin-Dependent Kinases (cdk Proteins)IBA
03/2022
1Neprilysin (Neutral Endopeptidase)IBA
02/2022
1Angiotensin Receptors (Angiotensin II Receptor)IBA
02/2022
1cariprazineIBA
01/2022
1NF-kappa B (NF-kB)IBA
01/2022
1Dopamine (Intropin)FDA LinkGeneric
01/2022

Therapy/Procedure

10Therapeutics
01/2021 - 04/2002
3Drug Therapy (Chemotherapy)
12/2018 - 02/2010